$1.70
-0.05-2.86%
At close: Dec 15, 4:00 PM EST
$1.84
0.148.24%
After Hours: Dec 12, 6:35 AM EST
Comments
Loading...
TherapeuticsMD Earnings Estimates, EPS & Revenue | NASDAQ:TXMD | Benzinga
TherapeuticsMD reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 12
EPS
$0.000
Quarterly Revenue
$784.00K
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$2.80M
Analyze the earnings history of TherapeuticsMD using advanced sorting and filters.
TherapeuticsMD (TXMD) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2023-11-14 | $-0.13 | $-0.05 | -160.0 % |
| Q2 | 2023-08-14 | $-0.24 | $-0.07 | -242.9 % |
| Q1 | 2023-05-15 | $-0.24 | $0.06 | -500.0 % |
| Q4 | 2023-04-07 | $-3.62 | $-1.11 | -226.1 % |
TherapeuticsMD (TXMD) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2023-11-14 | $-53.00K | $500.00K | -110.6 % |
| Q2 | 2023-08-14 | $437.00K | $500.00K | -12.6 % |
| Q1 | 2023-05-15 | $416.00K | $1.70M | -75.5 % |
| Q4 | 2023-04-07 | $1.15M | $23.80M | -95.2 % |
FAQ
When is TherapeuticsMD (NASDAQ:TXMD) reporting earnings?
TherapeuticsMD (TXMD) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 12, 2025 for Q3.
What were the latest earnings per share (EPS) for TherapeuticsMD (NASDAQ:TXMD)?
TherapeuticsMD (TXMD) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 12, 2025 for Q3 and the Actual EPS was $0.00, which hit the estimate of $0.00.
What were TherapeuticsMD’s (NASDAQ:TXMD) revenues?
TherapeuticsMD (TXMD) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 12, 2025 for Q3 and the Actual Revenue was $784K, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.
